✦ LIBER ✦

First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

✍ Scribed by Eichhorst, B. F.; Busch, R.; Stilgenbauer, S.; Stauch, M.; Bergmann, M. A.; Ritgen, M.; Kranzhofer, N.; Rohrberg, R.; Soling, U.; Burkhard, O.; Westermann, A.; Goede, V.; Schweighofer, C. D.; Fischer, K.; Fink, A.-M.; Wendtner, C. M.; Brittinger, G.; Dohner, H.; Emmerich, B.; Hallek, M.

Book ID: 118019042
Publisher: American Society of Hematology
Year: 2009
Tongue: English
Weight: 324 KB
Volume: 114
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2009-02-206185

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Health-Related Quality of Life in Younge

✍ Eichhorst, B. F.; Busch, R.; Obwandner, T.; Kuhn-Hallek, I.; Herschbach, P.; Hal 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 191 KB

Combination therapy with fludarabine and

Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma : A phase 2 trial of the Minnie Pearl Cancer Research Network

✍ John D. Hainsworth; Elizabeth R. Vazquez; David R. Spigel; Eric Raefsky; James D 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## BACKGROUND The purpose of the current study was to evaluate the efficacy and toxicity of the combination of fludarabine and rituximab, followed by alemtuzumab, as first‐line treatment for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). ## METHO

5.40 Rituximab Maintenance in Patients w

5.40 Rituximab Maintenance in Patients with Chronic Lymphocytic Leukemia after First-Line Treatment with Rituximab plus Fludarabine, Cyclophosphamide, and Mitoxantrone: Final Results of a Multicenter Phase II Trial on Behalf of the Spanish CLL Study Group (GELLC)

✍ Francesc Bosch; Pau Abrisqueta; Neus Villamor; María José Terol; Eva González-Ba 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 250 KB

5.44 Consolidation Therapy with Subcutan

5.44 Consolidation Therapy with Subcutaneous Alemtuzumab after Induction Treatment with Oral Fludarabine and Cyclophosphamide in Previously Untreated Patients Aged 65-70 years with Advanced Stage CLL: Final Results of a Phase II Study from the French Cooperative Group on Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia (FCG-CLL/WM)

✍ Alain Delmer; Olivier Tournilhac; Stéphane Leprêtre; Bruno Cazin; Pierre Feugier 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 113 KB